SINOMEM and EPURE were among the top volume stocks this morning, after Epure announced in the wee hours this morning of its plans to have a dual primary listing in Hong Kong.
As at the first half of today’s trading, Sinomem gained 5% and closed at 61 cents while Epure gained 7.3% and closed at 88.5 cents.
United Envirotech inched up 0.5 cents to 33.4 cents.
Not all water stocks were spurred, however. Asia Environment was down one cent, at 31 cents while Hyflux was down 4 cents, at S$3.58.
For our story which was published at 7 am today, read: BREAKING NEWS: Epure seeks dual listing in HK
Market darling Healthway was up another cent (5.7%) overnight on top volume, continuing its steady rise from 13 cents just last week. That’s a 42% gain in just one week!
At 18.5 cents, the stock still has upside of 51%, based on DMG’s 28-cent target issued on Mon (4 Jan).
Healthway currently operates the largest private network of medical centres in Singapore, providing primary care, dentistry and specialist services, but has clear plans to expand in China all the way to 2015.
By 2013, it plans to double the total number of its clinics in Singapore and China to 120.
The integrated healthcare player is proposing a rights issue to fund its investment in medical centers in China.
Net proceeds of about S$19.8 million will be raised from a rights issue at 7.5 cents per share on the basis of one new share for 5 shares held.
Some investors who got into the stock early have been sharing their insights on NextInsight’s forum.Click here.
NOL is another top volume stock that has been spiking steadily this first week of the year.
At S$1.82 as at the close of today’s first half trading session, the leading global container shipping line gained another 7 cents overnight, continuing its 10.3%-surge from S$1.65 at the end of last year.
Deutsche Bank upgraded the stock to “Buy” yesterday, and raised its 12-month target price to S$2.04 per share.
The analysts, Joe Liew and Sky Hong, are forecasting an operating loss of US$362.9 million for FY2009 but believe that earnings recovery momentum has improved and upped their forecast of FY10 operating profits to US$234.2 million.
The following key industry catalysts were highlighted:
(1) Demand recovery from restocking in US/Europe
(2) Continued freight rate rises especially after the annual Transpacific contract negotiations in May
(3) Newbuild supply coming in below expectations on the back of order cancellations and delivery delays.